Acta Scientific Microbiology (ISSN: 2581-3226)

Short Communication Volume 4 Issue 6

How Far Could these New SARS-CoV-2 Variants Take Us?

Fabiana Avila Carneiro1,2* and Lucio Ayres Caldas1,2

1Núcleo Multidisciplinar de Pesquisas em Biologia - NUMPEX-BIO, Campus Duque de Caxias Geraldo Cidade, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Duque de Caxias, RJ, Brazil
2Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil

*Corresponding Author: Fabiana Avila Carneiro, Núcleo Multidisciplinar de Pesquisa em Biologia - NUMPEX-BIO, Campus Duque de Caxias Geraldo Cidade, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Duque de Caxias, RJ, Brazil. Email: fcarneiro@caxias.ufrj.br

Received: April 14, 2021; Published: May 17, 2021

  COVID-19 first cases emerged in Wuhan, China, spreading across other countries, culminating in a global pandemic [1]. Regarding the analysis of the clinical characteristics of patients infected with the new coronavirus, although all ages are susceptible, the published studies showed an average age between 40 and 56 years and a higher incidence in men, but it is clear that more serious cases are related to older population and individuals with associated diseases (obesity, diabetes, heart disease) [2]. COVID-19 in some cases can progress to pneumonia, acute respiratory distress syndrome (ARDS) and multiple organ dysfunction [3].

References

  1. Zhu N., et al. “A Novel Coronavirus from Patients with Pneumonia in China, 2019”. The New England Journal of Medicine 382 (2020): 727-733.
  2. Li F., et al. “Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study”. Lancet Infectious Diseases 20 (2021): 30981-30986.
  3. Zaim S., et al. “COVID-19 and Multiorgan Response”. Current Problems in Cardiology8 (2020):100618-100640.
  4. Lauxmann M., et al. “The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak”. International Brazilian Journal of Urology 46 (2020): 6-18.
  5. Russell Y., et al. “Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion”. mBio Clinical Science and Epidemiology1 (2021):e03014-e03020.
  6. Li-Li Ren., et al. “Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study”. Chinese Medical Journal (Engl) 133.9 (2020): 1015-1024.
  7. World Health Organization. “WHO Coronavirus Disease (COVID-19) Dashboard” (2020).
  8. Hoffmann M., et al. “SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies”. Cell 9 (2021): 2384-2393.e12.
  9. Pan D., et al. “The new UK SARS-CoV-2 variant and lockdown - causes and consequences”. Clinical Medicine (Lond) (2021):clinmed.0019.
  10. Lauring AS., et al. “Genetic Variants of SARS-CoV-2-What Do They Mean?”. JAMA6 (2021):529-531.
  11. Luan B., et al. “Insights into SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival”. Journal of Medicinal Chemistry (2021).
  12. Giovanetti M., et al. “Molecular Epidemiology of HIV-1 in African Countries: A Comprehensive Overview”. Pathogens12 (2020):1072.

Citation

Citation: Fabiana Avila Carneiro and Lucio Ayres Caldas. “How Far Could these New SARS-CoV-2 Variants Take Us?". Acta Scientific Microbiology 4.6 (2021): 38-39.

Copyright

Copyright: © 2021 Fabiana Avila Carneiro and Lucio Ayres Caldas. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor0.614

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US